Results 31 to 40 of about 53,716 (254)

Extensively Drug-Resistant Mycobacterium tuberculosis from Aspirates, Rural South Africa

open access: yesEmerging Infectious Diseases, 2010
The yield from aspirating lymph nodes and pleural fluid for diagnosing extensively drug-resistant (XDR) tuberculosis is unknown. Mycobacterium tuberculosis was cultured from lymph node or pleural fluid aspirates of 21 patients; 7 (33%) cultures grew XDR ...
Scott K. Heysell   +9 more
doaj   +1 more source

Case Report: Primary Mediastinal Large B-Cell Lymphoma Invasion of Extranodal Thyroid Tissue Mimicking Tuberculosis and Confounded by Similar Ultrasonic Appearance

open access: yesFrontiers in Oncology, 2022
BackgroundPrimary mediastinal large B-cell lymphoma (PMBCL) is a rare type of diffuse large B-cell lymphoma, which has significant features that overlap with those of Hodgkin’s lymphoma.
Ying Wang   +6 more
doaj   +1 more source

Clinical value of Metagenomic Next- and Third-Generation Sequencing applied in ultrasound-guided puncture biopsy for diagnosing lymph node tuberculosis

open access: yesJournal of Microbiology, Immunology and Infection
Objectives: The aim of this study was to assess the clinical utility of metagenomic next-generation sequencing (mNGS) and metagenomic third-generation sequencing (mTGS) in diagnosing cervical lymph node tuberculosis through analysis of lymph node tissue.
Ting Lin   +10 more
doaj   +1 more source

A rare case of squamous inclusion cyst in cervical lymph node

open access: yesHeliyon, 2020
A 38-year-old man, with no history of malignancy, was found to have a 2 cm jugular lymph node, for which a lymph node tuberculosis was suspected. The specimen revealed a cystic structure lined by mature keratinizing squamous epithelium with a prominent ...
Y. Houcine   +4 more
doaj   +1 more source

Diagnostic dilemma in a patient with nasopharyngeal tuberculosis: A case report and literature review

open access: yesSAGE Open Medical Case Reports, 2022
Tuberculosis remains a major cause of morbidity and mortality globally, with a global total of about 10 million people falling ill with it in 2020. Until the coronavirus (COVID-19) pandemic, tuberculosis was the leading cause of death from a single ...
Dorji Penjor, Birendra Pradhan
doaj   +1 more source

Tuberculosis of Cystic Duct Lymph Node Associated with Cholecystitis

open access: yesThe Korean Journal of Gastroenterology, 2021
Tuberculosis of the cystic duct lymph node is very rare. Only four cases have been reported in the literature. This paper presents the case of a young male patient with a tuberculous cystic duct lymph node and chronic cholecystitis, who was diagnosed ...
Tae Gil Heo   +6 more
doaj   +1 more source

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance. [PDF]

open access: yes, 2015
In this study, 132 patients with lymphadenopathy were investigated. Fifty-two (39.4%) were diagnosed with tuberculosis (TB). The microscopic observation drug susceptibility (MODS) assay provided rapid (13 days), accurate diagnosis (sensitivity, 65.4 ...
Cabrera, JL   +12 more
core   +3 more sources

Tuberculosis axillary lymph node coexistent breast cancer in adjuvant treatment: case report

open access: yesEinstein (São Paulo)
Coexistence of breast cancer and tuberculosis is rare. In most cases, involvement by tuberculosis occurs in axillary lymph nodes. We report a case of a 43-years-old patient who had undergone adenomastectomy and left sentinel lymph node biopsy due to a ...
Silvio Eduardo Bromberg   +1 more
doaj   +1 more source

Immunohistochemical diagnosis of abdominal and lymph node tuberculosis by detecting complex specific antigen MPT64 [PDF]

open access: yes, 2007
Background: The aim of this study was to evaluate the diagnostic potential of immunohistochemistry using an antibody to the secreted mycobacterial antigen MPT64, in abdominal and lymph node tuberculosis.
Manju R Purohit   +4 more
core   +2 more sources

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy